Deschamps Philippe has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 5700 shares of Coeptis Therapeutics Holdings, Inc. ($COEP) on February 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Deschamps Philippe | Director | M | Common stock | 5700 | $10.56 | 8,950.0000 | 4,745,089 | 175.38% | 0.12% |
| Feb. 11, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Deschamps Philippe | Director | A | Common Stock | 3250 | $0.00 | 8,950.0000 | 4,745,089 | 57.02% | 0.07% |
| March 4, 2025 | Coeptis Therapeutics Holdings, Inc. | $COEP | Deschamps Philippe | Director | A | Non-qualified Stock Options (right to buy) | 5700 | $0.00 | 8,950.0000 | 1,924,639 | 175.38% | 0.30% |
| Jan. 27, 2023 | Coeptis Therapeutics Holdings, Inc. | $COEP | Deschamps Philippe | Director | A | Non-qualified Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |